MENU
PBYI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Puma Biotechnology (PBYI) Ownership - Who owns Puma Biotechnology?

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
181.18M
P/E Ratio
4.68
Total Cash
93.17M
Projected Growth
N/A
Total Debt
61.71M
Revenue
232.71M
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash/Share
1.88
Total Debt/Equity
N/A
Revenue/Share
4.70 USD as % of share price

Fundamentals

PBYI
Capitalization
181M
P/E Ratio
4.68
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash
93.2M
Total Cash/Share
1.88
Total Debt
61.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.70%
Revenue
233M
ROE
N/A
Book Value
97.1M
P/B Ratio
1.87
Cash Flow
N/A
Earnings
0.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
1.53
Current Revenue Per Employee
267482.56
Dividends Per Share - Security
N/A
EBITDA
54.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.06
Revenue To Assets
18.55
Shares Held By Institutions
112M
Shares Outstanding - Current
49.6M
Total Liabilities
99.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
16.721
View a ticker or compare two or three
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com